Pharmacogenomics Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacogenomics, including details on pharmacology, designer drugs, customized medicines.

Volume 2 (2006), Issue 2 (February)

1. Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data.
   Pharmacoepidemiol Drug Saf, 15(2): 99-105. [Abstract] [Full-text]
2. DNA based customized nutraceutical "gene therapy" utilizing a genoscore: a hypothesized paradigm shift of a novel approach to the diagnosis, stratification, prognosis and treatment of inflammatory processes in the human.
   Med Hypotheses, 66(5): 1008-18. [Abstract] [Full-text]
3. A call for the creation of personalized medicine databases.
   Nat Rev Drug Discov, 5(1): 23-6. [Abstract] [Full-text]
4. Cellular stress responses and molecular mechanisms of nephrotoxicity.
   Toxicol Lett, 162(1): 83-93. [Abstract] [Full-text]
5. Genetic basis of toxic reactions to drugs and chemicals.
   Toxicol Lett, 162(1): 16-28. [Abstract] [Full-text]
6. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.
   Nat Rev Cancer, 6(2): 130-40. [Abstract] [Full-text]
7. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
   Nat Rev Cancer, 6(2): 117-29. [Abstract] [Full-text]
8. Pharmacogenetics, adverse drug reactions and public health.
   Community Genet, 9(1): 50-4. [Abstract] [Full-text]
9. So many studies, too few subjects: establishing functional relevance of genetic polymorphisms on pharmacokinetics.
   J Clin Pharmacol, 46(3): 258-64. [Abstract] [Full-text]
10. Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.
    NeuroRx, 3(1): 106-16. [Abstract] [Full-text]
11. Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin.
    Thromb Haemost, 95(2): 205-11. [Abstract] [Full-text]
12. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
    Pharmacogenet Genomics, 16(3): 219-27. [Abstract] [Full-text]
13. Experimental validation of data mined single nucleotide polymorphisms from several databases and consecutive dbSNP builds.
    Pharmacogenet Genomics, 16(3): 207-17. [Abstract] [Full-text]
14. P2Y2 receptor polymorphisms and haplotypes in cystic fibrosis and their impact on Ca2+ influx.
    Pharmacogenet Genomics, 16(3): 199-205. [Abstract] [Full-text]
15. Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.
    Pharmacogenet Genomics, 16(3): 191-8. [Abstract] [Full-text]
16. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity.
    Pharmacogenet Genomics, 16(3): 183-90. [Abstract] [Full-text]
17. Rat brain DNA transcript profile of halothane and isoflurane exposure.
    Pharmacogenet Genomics, 16(3): 171-82. [Abstract] [Full-text]
18. Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis.
    Pharmacogenet Genomics, 16(3): 159-69. [Abstract] [Full-text]
19. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia.
    Pharmacogenet Genomics, 16(3): 151-7. [Abstract] [Full-text]

© 2005-2008 Pharmacogenomics Research Today. All Rights Reserved.